Microbial Control, Monitoring And Validation Of Water Systems For Pharmaceuticals And Biologics

Learn valuable insights and strategies from industry experts.

  • Expert-led Training
  • Industry Best Practices
  • Practical Implementation
  • Real-world Scenarios
Medical Devices Webinar Image
Date
31 December, 2017 (Sunday)
Time
0
Duration
60 Minutes

Overview

This webinar will discuss the FDA requirements for design, validation and monitoring of pharmaceutical water systems. There are many different types of pharmaceutical waters and each must be fit for its intended use. Pharma water must be controlled microbially and for other impurities. Pharma water systems must be designed, validated and monitored to ensure that the water produced meets specifications around the clock. Learn common pitfalls with water system design and use and how to avoid them. Get your pharma water questions answered in this webinar.

Area Covered

  • Pharmaceutical water types
  • Water requirements per product type
  • Water system requirements
  • Applicable regulations and guidances for pharmaceutical water
  • Water system design and unit operations
  • System validation and points to consider
  • Validation acceptance criteria and validation periods
  • Common pitfalls and how to avoid them
  • Control of biofilms
  • Sampling programs
  • Microbial control and monitoring
  • Use of process analytical technology (PAT) and rapid methods

Why Should You Attend

Attend this webinar to learn in depth about pharmaceutical water, how to design systems for appropriate microbial control; to learn the minimum requirements for validation of pharmaceutical water systems. Also learn the different types of pharmaceutical water and their requirements and fitness for intended use and more.

Who Will Benefit?

  • Professionals in the pharmaceutical and biologics industries, where high purity water systems are used, should attend this program. Those in QA, compliance lab personnel, R&D, and engineering would also benefit from this session.

Speaker

Gwen Wise-Blackman, Ph.D., has 20 years of combined experience in Cell-Based Assays and Quality Systems. She has worked at DuPont Pharmaceuticals, Catalent Pharma Solutions (formerly Magellan Laboratories and Cardinal Health), and Salix Pharmaceuticals. She is currently Principal Consultant at Gwen Wise-Blackman Consulting. Her career focus has been in High-Throughput Screening, Cell-Based Assay Method Development and Validation, and Quality Assurance. Gwen has a Bachelor of Science degree in biology from M.I.T and a PhD in Pharmacology from UVa. She is a member of ASQ and AAPS

Upcoming Webinars

View All Webinars